MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rheumatology/kez532

Медицинская библиотека · Rheumatology (Oxford, England) · 2020

The clinical and economic burden of systemic sclerosis related interstitial lung disease.

Morrisroe Kathleen, Stevens Wendy, Sahhar Joanne, Ngian Gene-Siew, Ferdowsi Nava, Hansen Dylan, Patel Shreeya, Hill Catherine L, Roddy Janet, Walker Jennifer, Proudman Susanna, Nikpour Mandana

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To quantify the burden of interstitial lung disease (ILD) in SSc.

METHODS

Clinical data for SSc patients enrolled in the Australian Scleroderma Cohort Study were linked with healthcare databases for the period 2008-2015. ILD was defined by characteristic fibrotic changes on high-resolution CT (HRCT) lung, while severity was defined by the extent lung involvement on HRCT (mild <10%, moderate 10-30%, severe >30%). Determinants of healthcare cost were estimated using logistic regression.

RESULTS

SSc-ILD patients utilized more healthcare resources, including hospitalization, emergency department presentation and ambulatory care services, than those without ILD with a total cost per patient of AUD$48 368 (26 230-93 615) vs AUD$33 657 (15 144-66 905), P<0.001) between 2008-2015. Healthcare utilization was associated with an annual median (25th-75th) excess cost per SSc-ILD patient compared with those without ILD of AUD$1192 (807-1212), P<0.001. Increasing ILD severity was associated with significantly more healthcare utilization and costs with an annual excess cost per patient with severe ILD compared with mild ILD of AUD$2321 (645-1846), P<0.001. ILD severity and the presence of coexistent PAH were the main determinants of overall healthcare cost above median for this SSc-ILD cohort (OR 5.1, P<0.001, and OR 2.6, P=0.01, respectively). Furthermore, SSc-ILD patients reported worse physical HRQoL compared with those without ILD [34.3 (10.5) vs 39.1 (10.8), P<0.001], with a progressive decline with increasing ILD severity (P=0.002).

CONCLUSION

SSc-ILD places a large burden on the healthcare system and the patient through poor HRQoL in addition to incremental healthcare resource utilization and associated direct cost.

Для цитирования: Morrisroe Kathleen, Stevens Wendy, Sahhar Joanne, Ngian Gene-Siew, Ferdowsi Nava, Hansen Dylan, Patel Shreeya, Hill Catherine L, Roddy Janet, Walker Jennifer, Proudman Susanna, Nikpour Mandana. The clinical and economic burden of systemic sclerosis related interstitial lung disease.. Rheumatology (Oxford, England). 2020. DOI: 10.1093/rheumatology/kez532.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.